News
The FDA has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis in patients aged 12 years and older who are AChR or anti-muscle-specific tyrosine kinase antibody ...
Early diagnosis and treatment of generalized myasthenia gravis (MG) are important to achieve symptomatic control and limit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback